Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 8 2 2019
medline: 8 2 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

The HTML version of this Article contained errors in Supplementary Figure S2 "Flowchart of the lyso-Gb3 screening and gene analysis in female patients", which have been detailed in the associated Correction.

Identifiants

pubmed: 30728527
doi: 10.1038/s41436-019-0447-8
pii: S1098-3600(21)01495-7
pmc: PMC7609257
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1263

Commentaires et corrections

Type : ErratumFor

Auteurs

Hiroki Maruyama (H)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. hirokim@med.niigata-u.ac.jp.

Kaori Miyata (K)

Sanofi K.K., Sanofi Genzyme Medical Operations, Rare Disease Medical, Medical Science Liaison, Tokyo, Japan.

Mariko Mikame (M)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Atsumi Taguchi (A)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Chu Guili (C)

Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Masaru Shimura (M)

Department of Metabolism, Chiba Children's Hospital, Chiba, Japan.

Kei Murayama (K)

Department of Metabolism, Chiba Children's Hospital, Chiba, Japan.

Takeshi Inoue (T)

Department of Pediatrics, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.

Saori Yamamoto (S)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Koichiro Sugimura (K)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.

Koichi Tamita (K)

Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan.

Toshihiro Kawasaki (T)

Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan.

Jun Kajihara (J)

Department of Cardiology, Fujinomiya City General Hospital, Fujinomiya, Japan.

Akifumi Onishi (A)

Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.

Hitoshi Sugiyama (H)

Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.

Teiko Sakai (T)

Sukoyaka Clinic, Gifu, Japan.

Ichijiro Murata (I)

Department of Chronic Kidney Disease, Gifu University Graduate School of Medicine, Gifu, Japan.

Takamasa Oda (T)

Yamaguchi Prefectural Grand Medical Center, Hofu, Japan.

Shigeru Toyoda (S)

Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.

Kenichiro Hanawa (K)

Department of Cardiology, Internal Medicine, Iwaki Kyoritsu General Hospital, Iwaki, Japan.

Takeo Fujimura (T)

Department of Nephrology, Kashiwazaki General Hospital and Medical Center, Kashiwazaki, Japan.

Shigehisa Ura (S)

Division of Neurology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.

Mimiko Matsumura (M)

Department of Nephrology, Tokyo Teishin Hospital, Tokyo, Japan.

Hideki Takano (H)

Department of Nephrology, Tokyo Teishin Hospital, Tokyo, Japan.

Satoshi Yamashita (S)

Department of Cardiology, Japanese Red Cross Hamamatsu Hospital, Hamamatsu, Japan.

Gaku Matsukura (G)

Department of Cardiology, Japanese Red Cross Hamamatsu Hospital, Hamamatsu, Japan.

Ryushi Tazawa (R)

Division of Medical Genetics, Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.

Tsuyoshi Shiga (T)

Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.

Mio Ebato (M)

Division of Cardiology, Showa University Fujigaoka Hospital, Yokohama, Japan.

Hiroshi Satoh (H)

Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Satoshi Ishii (S)

Glyco Pharma Corporation, Oita, Japan.

Classifications MeSH